The International Society of the Study of Celiac Disease (ISSCD) and Beyond Celiac are seeking applications for the ISSCD-Beyond Celiac Translational Research Award. The Award is a three-year grant of up to $100,000 USD annually, which includes up to 8% in indirect costs*.
The objective of the award is to encourage scientists to continue studying celiac disease or turn their focus on celiac disease if they work in a related field. Ultimately, the grant aims to secure a commitment and to keep celiac disease research on the long-term agenda of scientists.
The award is intended to support a translational research project, with the potential to advance disease knowledge and accelerate discovery and/or development of treatments for celiac disease. The funding period covers October 1, 2026, through September 30, 2029.
Phased Approach
The proposed project should be conducted using a three-phase approach in which the first phase, Phase 1, is intended for establishing the model and preliminary testing, for example: obtaining specimens, breeding animals, or establishing cell cultures.
The starts of Phase 2 and Phase 3 activities are contingent upon the completion of established milestones for Phase 1 and Phase 2, respectively.
Phase 1 activities will be conducted during Year 1 (months 1–12). Unless it can be accomplished more quickly or there is reason for delay, Phase 2 activities will be conducted during Year 2 (months 13–24), and Phase 3 activities will be conducted during Year 3 (months 25-36)
Candidates must submit a complete application through the ProposalCentral platform. In addition to the sections within the proposal, you must also upload the following documents in the Application Documents section:
Proposals will be completed within the ProposalCentral platform. Fill out each section as required.
To start your application, visit ProposalCentral, then click “Apply Now.”
Budget
A budget must be provided. You will enter your budget in the Budget Detail section of the application.
Funding requests may include:
Funding will not be provided for:
Awards made in response to proposals involving research on vertebrate animals and/or human subjects will be contingent upon receipt of copies of approval letters from the requisite regulatory and ethics bodies.
Duration of funding
Three years. Unexpended funds must be returned to Beyond Celiac at the end of the research period.
Interim progress reports must be submitted to the ISSCD and Beyond Celiac after six months, one year, 18 months, two years, and 30 months of support, within 5 business days of each of these deadlines. A final progress report must be submitted to the ISSCD and Beyond Celiac within 30 days of conclusion of the project and a financial statement from the institutional grants or accounting office must be received for final payment.
All publications arising from this award must include the following statement “This research was supported by “ISSCD-Beyond Celiac Translational Research Award (ISSCD-global.org) (BeyondCeliac.org).”
The primary criteria for the Award include the scientific merit of the proposal and the investigator’s qualifications. Additional criteria include the environment of the host institution and the availability of resources judged essential for the success of the proposed research
The application deadline is 6:00 PM ET on July 1, 2026. The application and all supporting materials must be submitted electronically in the requested format on ProposalCentral.
Technical questions about the grant submission process can be addressed online by Proposal Central Customer Service (pcsupport@altum.com). Other questions can be directed to Kate Avery at kavery@beyondceliac.org and Info@isscd-global.org
The grant recipient will be announced in October 2026. Awardees will be notified via email.
*Indirect/Facilities and Administration costs: Defined as laboratory costs, utilities costs and compliance costs.
👉 Non-celiac or loosely related GI research is rarely funded
👉 Incremental studies have low competitiveness
A defining feature:
👉 Key question:
“Will this help move us closer to a cure?”
👉 Pure basic research must show clear translational trajectory
Successful proposals often explore:
👉 Mechanism-driven research strengthens proposals
👉 Speed toward impact is valued
👉 Early-career applicants succeed with strong mentorship
👉 Overly ambitious proposals are frequently rejected
👉 Patient benefit must be explicit and measurable
Highest impact factors:
Moderate predictors:
4. Translational relevance
5. Mechanistic insight
6. Acceleration potential
Supporting factors:
7. Investigator expertise
8. Collaboration
9. Feasibility
Compared to other disease foundations:
👉 Key evaluation question:
“Will this research meaningfully accelerate a cure or new treatment for celiac disease?”
Applicants must have a PhD or MD (or equivalent) and hold a full-time position at an academic institution. Individuals holding other research funding are eligible for this award. However, the proposed research should be an extension of our departure from the aims proposed in other awards. The research is to be conducted at an academic institution with all the appropriate facilities and policies in place to undertake the proposed research.
Sponsor Institute/Organizations: Beyond Celiac
Sponsor Type: Corporate/Non-Profit
Address: PO Box 544, Ambler, PA 19002
Affiliation Disclaimer: Trialect operates independently and is not affiliated with, endorsed by, or supported by any sponsors or organizations posting on the GrantsBoard platform. As an independent aggregator of publicly available funding opportunities, Trialect provides equal access to information for all users without endorsing any specific funding source, content, organization, or sponsor. Trialect assumes no responsibility for the content posted by sponsors or third parties.
Subscription Disclaimer: Upon logging into Trialect, you may choose to SUBSCRIBE to GrantsBoard for timely notifications of funding opportunities and to access exclusive benefits, such as priority alerts, reminders, personalized recommendations, and additional application support. However, users are advised to contact sponsors directly for any questions and are not required to subscribe to engage with funding opportunities.
Content Ownership and Copyright Disclaimer: Trialect respects the intellectual property rights of all organizations and individuals. All content posted on GrantsBoard is provided solely for informational purposes and remains the property of the original owners. Trialect does not claim ownership of, nor does it have any proprietary interest in, content provided by third-party sponsors. Users are encouraged to verify content and ownership directly with the posting sponsor.
Fair Use Disclaimer: The information and content available on GrantsBoard are compiled from publicly accessible sources in alignment with fair use principles under U.S. copyright law. Trialect serves as an aggregator of this content, offering it to users in good faith and with the understanding that it is available for public dissemination. Any organization or individual who believes their intellectual property rights have been violated is encouraged to contact us for prompt resolution.
Third-Party Posting Responsibility Disclaimer: Trialect is a neutral platform that allows third-party sponsors to post funding opportunities for informational purposes only. Sponsors are solely responsible for ensuring that their postings comply with copyright, trademark, and other intellectual property laws. Trialect assumes no liability for any copyright or intellectual property infringements in third-party content and will take appropriate action to address any substantiated claims.
Accuracy and Verification Disclaimer: Trialect makes no warranties regarding the accuracy, completeness, or reliability of the information provided by sponsors. Users are advised to verify the details of any funding opportunity directly with the sponsor before taking action. Trialect cannot be held liable for any discrepancies, omissions, or inaccuracies in third-party postings.
Notice and Takedown Policy: Trialect is committed to upholding copyright law and protecting the rights of intellectual property owners. If you believe that content on GrantsBoard infringes your copyright or intellectual property rights, please contact us with detailed information about the claim. Upon receipt of a valid notice, Trialect will promptly investigate and, where appropriate, remove or disable access to the infringing content.
Jul 01, 2026
Jul 01, 2026
$100,000
Affiliation: Beyond Celiac
Address: PO Box 544, Ambler, PA 19002
Website URL: https://www.beyondceliac.org/research/grants/isscd-beyond-celiac-translational-research-award/
Disclaimer:It is mandatory that all applicants carry workplace liability insurance, e.g., https://www.protrip-world-liability.com (Erasmus students use this package and typically costs around 5 € per month - please check) in addition to health insurance when you join any of the onsite Trialect partnered fellowships.